Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tarsus Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TARS
Nasdaq
8731
https://www.tarsusrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tarsus Pharmaceuticals Inc
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
- Apr 19th, 2024 11:35 am
Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
- Apr 8th, 2024 1:55 pm
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
- Apr 4th, 2024 3:33 pm
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
- Apr 1st, 2024 4:00 pm
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%
- Mar 6th, 2024 2:55 pm
Tarsus to Participate at Upcoming Investor Conferences
- Mar 5th, 2024 9:30 pm
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
- Mar 5th, 2024 1:30 pm
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates
- Mar 1st, 2024 7:50 pm
Tarsus Announces Pricing of $100.0 Million Public Offering
- Mar 1st, 2024 5:07 am
Tarsus Announces Proposed $100.0 Million Public Offering
- Feb 29th, 2024 9:37 pm
Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts
- Feb 29th, 2024 11:37 am
Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy
- Feb 28th, 2024 5:00 pm
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 2:58 pm
Tarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
- Feb 28th, 2024 11:09 am
Q4 2023 Tarsus Pharmaceuticals Inc Earnings Call
- Feb 28th, 2024 4:13 am
Tarsus Pharmaceuticals Inc (TARS) Reports Robust Q4 and Full-Year 2023 Financial Results
- Feb 27th, 2024 11:34 am
Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
- Feb 27th, 2024 11:00 am
Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease
- Feb 22nd, 2024 1:00 pm
Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024
- Feb 20th, 2024 10:00 pm
When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?
- Feb 1st, 2024 12:20 pm
Scroll